NO3045469T3 - - Google Patents

Info

Publication number
NO3045469T3
NO3045469T3 NO16151398A NO16151398A NO3045469T3 NO 3045469 T3 NO3045469 T3 NO 3045469T3 NO 16151398 A NO16151398 A NO 16151398A NO 16151398 A NO16151398 A NO 16151398A NO 3045469 T3 NO3045469 T3 NO 3045469T3
Authority
NO
Norway
Application number
NO16151398A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3045469T3 publication Critical patent/NO3045469T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO16151398A 2015-01-15 2016-01-15 NO3045469T3 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20155027A FI126143B (en) 2015-01-15 2015-01-15 Polymyxine derivative and its uses

Publications (1)

Publication Number Publication Date
NO3045469T3 true NO3045469T3 (no) 2018-04-28

Family

ID=55310836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO16151398A NO3045469T3 (no) 2015-01-15 2016-01-15

Country Status (19)

Country Link
EP (1) EP3045469B1 (no)
JP (1) JP6471236B2 (no)
KR (1) KR102020886B1 (no)
CN (1) CN107207569B (no)
AU (1) AU2016207942B2 (no)
CA (1) CA2972743C (no)
DK (1) DK3045469T3 (no)
ES (1) ES2656562T3 (no)
FI (1) FI126143B (no)
HR (1) HRP20180180T1 (no)
HU (1) HUE035778T2 (no)
IL (1) IL253457B (no)
MX (1) MX2017009094A (no)
NO (1) NO3045469T3 (no)
PT (1) PT3045469T (no)
RU (1) RU2675819C1 (no)
SG (1) SG11201705125UA (no)
TW (1) TWI694087B (no)
WO (1) WO2016113470A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3556769B1 (en) * 2016-12-16 2023-06-14 Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences Polymyxin derivative, preparation method and application thereof
GB201703898D0 (en) 2017-03-10 2017-04-26 Helperby Therapeautics Ltd Method
GB201704620D0 (en) 2017-03-23 2017-05-10 Helperby Therapeautics Ltd Combinations
CN107661349A (zh) * 2017-11-24 2018-02-06 刘晓峰 一种治疗小儿高热的联合用药物
CN110179967A (zh) * 2019-05-28 2019-08-30 中国医药集团总公司四川抗菌素工业研究所 多粘菌素母核和一种抗生素的组合物及其应用
IT201900025414A1 (it) 2019-12-23 2021-06-23 Univ Bologna Alma Mater Studiorum Composto per il trattamento della sindrome emolitico uremica
WO2022206826A1 (zh) * 2021-03-31 2022-10-06 江苏奥赛康药业有限公司 一种多粘菌素衍生物的硫酸盐及其药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754411A (fr) * 1969-08-05 1971-02-04 Rhone Poulenc Sa Cyclopeptides derives des polymyxines et leur
TW274552B (no) * 1992-05-26 1996-04-21 Hoechst Ag
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
EP3078672A1 (en) * 2006-08-11 2016-10-12 Northern Antibiotics Oy Polymyxin derivatives and uses thereof
US7807637B2 (en) 2006-08-11 2010-10-05 Northern Antibiotics Oy Polymyxin derivatives and uses thereof
FI20085469A0 (fi) * 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
MX355217B (es) 2011-11-18 2018-04-10 New Pharma Licence Holdings Ltd Derivados de polimixina.
CA2895910C (en) * 2013-01-11 2021-12-21 Xellia Pharmaceuticals Aps Polymyxins, compositions, methods of making and methods of use
PL2999711T3 (pl) 2013-05-22 2022-09-26 Spero Therapeutics, Inc. Pochodne polimyksyny i ich zastosowanie w terapii skojarzonej razem z różnymi antybiotykami

Also Published As

Publication number Publication date
SG11201705125UA (en) 2017-07-28
KR102020886B1 (ko) 2019-09-16
TWI694087B (zh) 2020-05-21
EP3045469B1 (en) 2017-11-29
FI20155027A (fi) 2016-07-15
RU2675819C1 (ru) 2018-12-25
FI126143B (en) 2016-07-15
JP6471236B2 (ja) 2019-02-13
AU2016207942A1 (en) 2017-08-10
CA2972743A1 (en) 2016-07-21
MX2017009094A (es) 2018-03-01
ES2656562T3 (es) 2018-02-27
BR112017014670A2 (pt) 2018-03-13
IL253457B (en) 2019-10-31
CN107207569A (zh) 2017-09-26
EP3045469A1 (en) 2016-07-20
HRP20180180T1 (hr) 2018-03-09
HUE035778T2 (hu) 2018-08-28
CN107207569B (zh) 2020-11-03
AU2016207942B2 (en) 2018-05-10
TW201630930A (zh) 2016-09-01
JP2018505868A (ja) 2018-03-01
KR20170102005A (ko) 2017-09-06
IL253457A0 (en) 2017-09-28
DK3045469T3 (en) 2018-03-05
WO2016113470A1 (en) 2016-07-21
CA2972743C (en) 2020-06-09
PT3045469T (pt) 2018-02-08

Similar Documents

Publication Publication Date Title
BR112017026362A2 (no)
BE2015C044I2 (no)
BR0008874B1 (no)
CN303069973S (no)
BR0000695B1 (no)
BR0000763F1 (no)
BR0001536B1 (no)
BR0001684B1 (no)
BR0001810B1 (no)
BR0002033B1 (no)
BR0002402B1 (no)
BR0002435B1 (no)
BR0002694B1 (no)
BR0002802B1 (no)
BR0002874B1 (no)
BR0003166B1 (no)
BR0003189B1 (no)
BR0003208B1 (no)
BR0003401B1 (no)
BR0003686B1 (no)
BR0003746B1 (no)
BR0003751B1 (no)
BR0003928B1 (no)
BR0004687B1 (no)
BR0005041B1 (no)